Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Fish and Richardson
Teva
Express Scripts
Cantor Fitzgerald
Farmers Insurance
Accenture
Johnson and Johnson
Moodys

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 008922

« Back to Dashboard

NDA 008922 describes CALCIUM DISODIUM VERSENATE, which is a drug marketed by Medicis and is included in one NDA. It is available from one supplier. Additional details are available on the CALCIUM DISODIUM VERSENATE profile page.

The generic ingredient in CALCIUM DISODIUM VERSENATE is edetate calcium disodium. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the edetate calcium disodium profile page.
Summary for 008922
Tradename:CALCIUM DISODIUM VERSENATE
Applicant:Medicis
Ingredient:edetate calcium disodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 008922
Suppliers and Packaging for NDA: 008922
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CALCIUM DISODIUM VERSENATE edetate calcium disodium INJECTABLE;INJECTION 008922 NDA Medicis Pharmaceutical Corp 99207-240 N 99207-240-05
CALCIUM DISODIUM VERSENATE edetate calcium disodium TABLET;ORAL 008922 NDA Medicis Pharmaceutical Corp 99207-240 N 99207-240-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength200MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Fish and Richardson
Colorcon
Harvard Business School
Chubb
Covington
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.